Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment

Vivek Subbiah, Luis Paz-Ares, Benjamin Besse, Victor Moreno, Solange Peters, María Angeles Sala, José Antonio López-Vilariño, Cristian Fernández, Carmen Kahatt, Vicente Alfaro, Mariano Siguero, Ali Zeaiter, Khalil Zaman, Rafael López, Santiago Ponce, Valentina Boni, Jennifer Arrondeau, Jean Pierre Delord, Maite Martínez, Luciano WannessonAntonio Antón, Javier Valdivia, Ahmad Awada, Rebecca Kristeleit, Maria Eugenia Olmedo, María Jesús Rubio, John Sarantopoulos, Sant P. Chawla, Joaquín Mosquera-Martinez, Manolo D’ Arcangelo, Armando Santoro, Victor M. Villalobos, Jacob Sands, José Trigo

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences